Related Experiment Video
Updated: Mar 31, 2026

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells
Published on: September 28, 2017
Disrupted circadian control promotes oncogenesis in breast cancer
Yasmin Fatima1, Mohammad Kashif2, Prashant Ankur Jain1
1Department of Computational Biology and Bioinformatics, Sam Higginbottom Institute of Agriculture, Technology and Sciences, Prayagraj, Uttar Pradesh, India.
None:
Breast cancer progression is increasingly linked to disturbances in circadian rhythm genes, although the underlying molecular mechanisms remain poorly understood. Circadian rhythm genes help maintain normal biological processes and their disruption contributes to breast cancer development. Transcriptomic data from breast cancer (MCF-7) and normal breast (MCF-10A) cell lines from the GSE76370 dataset were analyzed using the limma R package to identify differentially expressed genes. Functional enrichment and network analyses using GO, KEGG, STRING and Cytoscape revealed 1,788 DEGs, including 1,008 upregulated genes involved in DNA replication, chromatin remodeling and PI3K-Akt signaling and 780 downregulated genes associated with cell adhesion and apoptosis. Disrupted expression of core circadian genes (BMAL1, CLOCK and PER3) and hub genes such as ACTB, GAPDH and CDK1 suggests that circadian gene dysregulation promotes breast cancer progression and represents a potential therapeutic target.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Circadian Rhythms and Gene Regulation
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Inhibition of Cdk Activity

